FLEXION THERAPEUTICS INC - COM (FLXN)

CUSIP: 33938J106

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
13,514,310
Share change
-1,455,327
Total reported value
$124,100,000
Put/Call ratio
0%
Price per share
$9.20
Number of holders
65
Value change
-$47,772,541
Number of buys
44
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q1 2016

As of 31 Mar 2016, FLEXION THERAPEUTICS INC - COM (FLXN) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,514,310 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, Capital World Investors, Bank of New York Mellon Corp, WASATCH ADVISORS INC, DRIEHAUS CAPITAL MANAGEMENT LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., BlackRock Fund Advisors, WELLINGTON MANAGEMENT GROUP LLP, WELLS FARGO & COMPANY/MN, and VANGUARD GROUP INC. This page lists 65 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.